Journal Mobile Options
Table of Contents
Vol. 206, No. 1, 2003
Issue release date: 2003

Comedogenesis: Some Aetiological, Clinical and Therapeutic Strategies

Cunliffe W.J. · Holland D.B. · Clark S.M. · Stables G.I.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Hypercornification is an early feature of acne and usually precedes inflammation. It is associated with ductal hyperproliferation, and there are many controlling factors such as androgens, retinoids, sebum composition and cytokines. Cycling of normal follicles and of comedones may explain the natural resolution of comedones and, in the longer term, resolution of the disease itself. There is a need to tailor treatment according to comedonal type. Suboptimal therapy can often result from inappropriate assessments of comedones, especially microcomedones, sandpaper comedones, submarine comedones and macrocomedones. Macrocomedones can produce devastating acne flares, particularly if patients are inappropriately prescribed oral isotretinoin. Gentle cautery under topical local anaesthesia is a useful therapy in the treatment of such lesions. The newer retinoids and new formulations of all-trans-retinoic acid show a better benefit/risk ratio.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Cunliffe WJ, Simpson NB: Disorders of the sebaceous gland; in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology, ed 6. Oxford, Blackwell Science, 1998, pp 1927–1984.
  2. Burton JL, Shuster S: The relationship between seborrhoea and acne vulgaris. Br J Dermatol 1971:84:600–601.
  3. Leyden JL, McGinley KJ, Mills OH, et al: Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:382–384.
  4. Webster GF: Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33:247–253.
  5. Holmes RL, Williams M, Cunliffe WJ: Pilosebaceous duct obstruction and acne. Br J Dermatol 1972;87:327–332.
  6. Plewig G, Fulton JE, Kligman AM: Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971;242:12–29.
  7. Knaggs HE, Holland DB, Morris C, et al: Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Soc Invest Dermatol 1994;102:89–92.
  8. Hughes BR, Morris C, Cunliffe WJ, Leigh IM: Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol 1996;134:247–256.
  9. Holland DB, Roberts SG, Cunliffe WJ: Localisation of keratin 6 mRNA in acne (abstract). J Invest Dermatol 1994;103:443.
  10. Knaggs HE, Hughes BR, Morris C, et al: Immunohistochemical study of desmosomes in acne vulgaris. Br J Dermatol 1994;130:731–737.
  11. Kligman AM, Katz AC: Pathogenesis of acne vulgaris. I. Comedogenic properties of human sebum in external ear canal of the rabbit. Arch Dermatol 1968;98:53–57.
  12. Motoyoshi K: Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983;109:191–198.
  13. Downing DT, Stewart ME, Wertz PW, et al: Essential fatty acids and acne. J Am Acad Dermatol 1986;14:221–225.
  14. Thiboutot DM, Knaggs H, Gilliland K, Hagari S: Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997;136:166–167.
  15. Stewart ME, Greenwood R, Cunliffe WJ, et al: Effect of cyproterone acetate-ethinyl oestradiol treatment on the proportion of linoleic and sebaceous acids in various skin surface lipid classes. Arch Dermatol Res 1986;278:481–485.
  16. Chalker DK, Lesher JL, Smith JG, et al: Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: Results of a multicenter, double-blind investigation. J Am Acad Dermatol 1987;17:251–254.
  17. Shalita A, Weiss JS, Chalker DK, et al: A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial. J Am Acad Dermatol 1996;34:482–485.
  18. Kligman AM: The treatment of acne with topical retinoids: One man’s opinion. J Am Acad Dermatol 1997;36:S92–S95.
  19. Guy R, Green MR, Kealey T: Modelling acne in vitro. J Invest Dermatol 1996;106:176–182.
  20. Sanders DA, Philpott MP, Nicolle FV, Kealey T: The isolatioin and maintenance of the human pilosebaceous unit. Br J Dermatol 1994;131:166–176.
  21. Aldana OL, Holland DB, Cunliffe WJ: Variation in pilosebaceous duct keratinocyte proliferation in acne patients. Dermatology 1998;196:98–99.
  22. Norris JFB, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988;118:651–659.
  23. Hughes BR, Norris JF, Cunliffe WJ: A double-blind evaluation of topical isotretinoin 0.05% benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol 1992;17:165–168.
  24. Elbaum DJ: Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol 1988;19:486–491.
  25. Verschoore M, Langner A, Wolska H, et al: Efficacy and safety of CD271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:368–371.
  26. Pepall LM, Cosgrove MP, Cunliffe WJ: Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol 1991;125:256–259.
  27. Yip J, Pepall LM, Gawkrodger DJ, Cunliffe WJ: Light cautery and EMLA® in the treatment of chloracne lesions. Br J Dermatol 1993;128:313–316.
  28. Bottomley WW, Yip J, Knaggs H, Cunliffe WJ: Treatment of closed comedones – Comparisons of fulguration with topical tretinoin and electrocautery with fulguration. Dermatology 1993;186:253–257.
  29. Plewig G, Kligman AM: Induction of acne by topical steroids. Arch Dermatol Forsch 1973;247:29–52.
  30. Monk B, Cunliffe WJ, Layton AM, Rhodes DJ: Acne induced by inhaled corticosteroids. Clin Exp Dermatol 1993;18:148–150.
  31. White Gl Jr, Tyler LS: Blackmarket steroids complicate acne therapy (letter). J Fam Pract 1987;25:214.
  32. Fyrand O, Fiskdaadal HJ, Trygstad O: Acne in pubertal boys undergoing treatment with androgens. Acta Derm Venereol (Stockh) 1992;72:148–149.
  33. Crow KD: Chloracne and its potential clinical implications. Clin Exp Dermatol 1981;6:243–257.
  34. Rosas-Vasquez E, Campos-Macias P, Ochoa-Tirado JG, et al: Chloracne in the 1990s. Int J Dermatol 1996;35:643–645.
  35. McConnell R, Anderson K, Russell W, et al: Angiosarcoma, porphyria cutanea tarda and probable chloracne in a worker exposed to waste oil contaminated with a 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Ind Med 1993;50:699–703.
  36. Coenraads PJ, Brouwer A, Olie K, Tang N: Chloracne: Some recent issues. Dermatol Clin 1994;12:569–576.
  37. Beck MH, Dave VK: Extensive nevus comedonicus. Arch Dermatol 1980;116:1048–1050.
  38. Barsky S, Doyle JA, Winkelmann RK: Nevus comedonicus with epidermolytic hyperkeratosis: A report of our cases. Arch Dermatol 1981;117:86–88.
  39. Munro CS, Wilkie AOM: Epidermal mosaicism producing localised acne: Somatic mutation in FGFR2. Lancet 1998;352:704–705.
  40. Burns RE, Colville JM: Acne conglobata with septicaemia. Arch Dermatol 1959;79:361–363.
  41. Williamson DM, Cunliffe WJ, Gatecliff M, Scott DG: Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol 1977;2:351–354.
  42. Quigley JW, Bucks DAW: Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: A summary of preclinical and clinical investigations. J Am Acad Dermatol 1998;38:S5–S10.
  43. Embil K, Nacht S: The microsponge delivery system (MDS): A topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 1996;13:575–588.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50